Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial

Mayo Clinic · NCT07618273

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–44 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
50
US sites recruiting
1
Study start
April 20, 2026
Record last updated
June 5, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This clinical trial compares the impact of the Smart Symptom Tracking ALEX application (app) to standard symptom-tracking practices in tracking and monitoring gastrointestinal (GI) symptoms in young adults. Rates of early-onset colorectal cancer are rising sharply and it is projected to become the leading cause of cancer-related death in young adults. Despite this, adults under 45 still face barriers to diagnosis, including access to screening, unclear guidance on the impact of GI symptoms and dismissal of symptoms by healthcare providers. Current screening guidelines lack guidance on monitoring early symptoms in younger adults. The Smart Symptom Tracking ALEX tool is a digital platform that uses artificial intelligence to provide prompts for symptoms, coaching, reminders and education. Standard of care clinical practices include paper-based logs to report symptoms. Using the Smart Symptom Tracking ALEX app may provide more detailed symptom reports and increase self-reported symptom communication compared to standard symptom-tracking practices in young adults concerned about their GI health.

Being studied: Artificial Intelligence-based Intervention; Best Practice; Communication Intervention; Questionnaire Administration

Conditions: Colorectal Carcinoma

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Ages 18-44 years
  • Concerned about their GI health
  • Able to speak and read English
  • Willing to complete a four-week symptom tracking protocol

Exclusion Criteria

  • Unable to understand the informed consent or comply with protocol requirements

Recruiting US locations

  • Mayo Clinic in Florida

    Jacksonville, FL 32224-9980

    Site contact: Enhancing Technology & Communication in Healthcare (ETCH) Lab · 904-953-5375 · ETCH@mayo.edu

Study contacts (from the official record)

  • Enhancing Technology & Communication in Healthcare (ETCH) Lab · 904-953-5375 · ETCH@mayo.edu
  • Clinical Trials Referral Office · 855-776-0015 · mayocliniccancerstudies@mayo.edu
Smart Symptom Tracking ALEX Application for Tracking and… (NCT07618273) | Bored Studies